Osteoclast-derived exosomes promote medication-related osteonecrosis of the jaw by delivering glycoRNA to disrupt the blood-lymphatic vascular network. [PDF]
Zhang J, Tao J, Zhao C, Pan J.
europepmc +1 more source
Successful Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Surgically Treated by the Fragmentation Technique: A Case Report. [PDF]
Engoue JM +4 more
europepmc +1 more source
Postoperative healing and recurrence in osteonecrosis of the jaw: influence of risk factors and surgical approach. [PDF]
Mohr J +9 more
europepmc +1 more source
Fluvastatin enhances healing of medication-related osteonecrosis of the jaw (MRONJ) via macrophage polarization in a rat MRONJ-like model. [PDF]
Tazaki M +5 more
europepmc +1 more source
Medication-related osteonecrosis of the jaw in an adult with osteogenesis imperfecta: a case report. [PDF]
Zhu WY, Wan W, Wu PA, Zhou LW.
europepmc +1 more source
Medication-Related Osteonecrosis of the Jaw in a Patient With Prostate Cancer: A Case Presentation With a One-Month Follow-Up. [PDF]
Kachouh CF +5 more
europepmc +1 more source
Medial femoral condyle free flap for reconstructions of medication related osteonecrosis of the jaw. [PDF]
Wenger DC +4 more
europepmc +1 more source
Advanced Platelet-Rich Fibrin in Surgical Management of Medication-Related Osteonecrosis of the Jaw: A Prospective Case Series Study. [PDF]
Hajdari B +5 more
europepmc +1 more source
Radiographic Patterns and Clinical Correlates of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Analysis. [PDF]
Sevimay MA, Çetiner S.
europepmc +1 more source
Advanced biomaterial-based approaches for medication-related osteonecrosis of the jaw. [PDF]
Huang R, Jia S, Yin W.
europepmc +1 more source

